www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Updates-Strategic-Direction-and-Terminates-Exchange-Offer-423543 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> PharmaNet Development Group, Inc. (the "Company”) (NASDAQ: PDGI), announced today that it is working ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Updates-Strategic-Direction-and-Terminates-Exchange-Offer-423543http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Announces-Exchange-Offer-for-Its-Outstanding-2-25-Convertible-Senior-Notes-Due-2024-411988 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwtextalignleft {text-align: left} .bwunderlinestyle {text-decoration: underline} --> </style> PharmaNet Development Group, Inc. (the "Company”) (NASDAQ: PDGI), ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Announces-Exchange-Offer-for-Its-Outstanding-2-25-Convertible-Senior-Notes-Due-2024-411988http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Announces-Exchange-Offer-for-Its-Outstanding-2-25-Convertible-Senior-Notes-Due-2024-411994 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwtextalignleft {text-align: left} .bwunderlinestyle {text-decoration: underline} --> </style> PharmaNet Development Group, Inc. (the "Company”) (NASDAQ: PDGI), ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Announces-Exchange-Offer-for-Its-Outstanding-2-25-Convertible-Senior-Notes-Due-2024-411994http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Reports-Third-Quarter-2008-Preliminary-Financial-Results-400629 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft10 {padding-left: 50.0px} .bwcellpaddingleft2 {padding-left: 10.0px} .bwcellpaddingleft4 ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Reports-Third-Quarter-2008-Preliminary-Financial-Results-400629http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Inc-to-Announce-Third-Quarter-2008-Financial-Results-on-October-29-2008-385640 <style type="text/css"> <!-- .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft1 {padding-left: 5.0px} .bwcellpaddingright0 {padding-right: 0.0px} .bwcellparagraphmargin {margin-bottom: 0px; margin-top: 0px} .bwtablebottommargin {margin-bottom: ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Inc-to-Announce-Third-Quarter-2008-Financial-Results-on-October-29-2008-385640http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-to-Present-at-the-UBS-Global-Life-Sciences-Conference-on-September-24-2008-381065 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> PharmaNet Development Group, Inc., (the <span id="bwanpa2">"Company<span id="bwanpa3">”) (NASDAQ: PDGI), ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-to-Present-at-the-UBS-Global-Life-Sciences-Conference-on-September-24-2008-381065http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Updates-2008-Guidance-378550 <style type="text/css"> <!-- .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellparagraphmargin {margin-bottom: 0px; margin-top: 0px} .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtablebottommargin {margin-bottom: 10.0px} .bwtextaligncenter {text-align: ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Updates-2008-Guidance-378550http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Reports-Second-Quarter-2008-Financial-Results-361418PharmaNet Development Group, Inc. (the "Company”) (NASDAQ: PDGI), a leading provider of clinical development services, today reported net income for the second quarter ended June 30, 2008, of $2.2 million, or $0.11 per diluted share, ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Reports-Second-Quarter-2008-Financial-Results-361418http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Restores-Credit-Line-355319PharmaNet Development Group, Inc. (the "Company”) (NASDAQ: PDGI), a leading provider of clinical development services, today announces that it has successfully reached an agreement with its bank lending group to restore the availability ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Restores-Credit-Line-355319http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Inc-to-Announce-Second-Quarter-2008-Financial-Results-on-July-31-2008-348998PharmaNet Development Group, Inc. (the "Company”) (NASDAQ: PDGI), a leading provider of clinical development services, today announced that it will release its second quarter 2008 financial results on Thursday, July 31, 2008, before ...http://www.finanzen.net/nachricht/aktien/PharmaNet-Development-Group-Inc-to-Announce-Second-Quarter-2008-Financial-Results-on-July-31-2008-348998